543220 logo

Max Healthcare Institute Limited Stock Price

BSE:543220 Community·₹1.1t Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 13 Fair Values set on narratives written by author

543220 Share Price Performance

₹0
-1255.15 (-100.00%)
₹914.04
Fair Value
₹0
-1255.15 (-100.00%)
Price ₹0

543220 Community Narratives

·
Fair Value ₹914.04 18.6% overvalued intrinsic discount

Northern India Risks And Rising Capex Will Burden Future Operations

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value ₹1.2k 9.8% undervalued intrinsic discount

Expanding Premium Healthcare In India Will Meet Rising Demand

0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
·
Fair Value ₹1.37k 20.9% undervalued intrinsic discount

Rising Disposable Incomes And Aging Populations Will Drive Healthcare Demand

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
₹1.37k
20.9% undervalued intrinsic discount
Revenue
33.59% p.a.
Profit Margin
17.56%
Future PE
54.45x
Price in 2029
₹1.95k
₹914.04
18.6% overvalued intrinsic discount
Revenue
17.01% p.a.
Profit Margin
19.07%
Future PE
49.57x
Price in 2029
₹1.3k
₹1.2k
9.8% undervalued intrinsic discount
Revenue
28.03% p.a.
Profit Margin
17.86%
Future PE
54.15x
Price in 2029
₹1.71k

Trending Discussion

No trending discussion available.

Updated Narratives

543220 logo

543220: Lucknow Hospital Expansion Will Support Stronger Long-Term Upside Potential

Fair Value: ₹1.37k 20.9% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
543220 logo

543220: Lucknow Expansion And High P E Will Pressure Rich Valuation

Fair Value: ₹914.04 18.6% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
543220 logo

543220: Kalinga Hospital Acquisition Plans Will Support Continued Upside Ahead

Fair Value: ₹1.2k 9.8% undervalued intrinsic discount
9 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

High growth potential with solid track record.

0 Risks
2 Rewards

Max Healthcare Institute Limited Key Details

₹83.7b

Revenue

₹31.5b

Cost of Revenue

₹52.3b

Gross Profit

₹37.8b

Other Expenses

₹14.4b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
14.82
62.42%
17.23%
27.0%
View Full Analysis

About 543220

Founded
2001
Employees
15114
CEO
Abhay Soi
WebsiteView website
www.maxhealthcare.in

Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, Internal Medicine, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home, a platform that offers health and wellness services at home; and MaxLab, which provides diagnostic testing services to patients. In addition, it provides organ and tissue donation, preventive health checks, ambulance services, immigration services, air ambulance, and insurance and TPA services. The company operates through a network of healthcare facilities, including hospitals and medical centres. The company was incorporated in 2001 and is based in Gurugram, India.

Recent 543220 News & Updates

Narrative Update Jul 12

543220: Lucknow Hospital Expansion Will Support Stronger Long-Term Upside Potential

Analysts have lifted their price target for Max Healthcare Institute from ₹1,300 to ₹1,370, citing updated assumptions for revenue growth, profit margins and future P/E levels. What's in the News for Max Healthcare Institute Board meeting on May 21, 2026, to review standalone and consolidated financial results for the quarter and year ended March 31, 2026; consider a final dividend on equity shares for FY 2025-26; and review the reappointment of cost auditors.
Narrative Update Jun 28

543220: Upcoming Expansion Projects Will Support Stronger Long-Term Upside Potential

Analysts have trimmed their price target for Max Healthcare Institute from ₹1,500 to ₹1,300, citing updated assumptions around revenue growth, profit margins, a slightly higher discount rate, and a revised future P/E expectation. What’s in the News for Max Healthcare Institute Board meeting on May 21, 2026, to review and approve standalone and consolidated financial results for the quarter and year ended March 31, 2026, consider a final dividend on equity shares, and review the reappointment of cost auditors.

Recent updates

No updates

Max Healthcare Institute Limited Competitors